The resumption of trading for ASLAN Pharmaceuticals and the subsequent spike in share price directly impacts the stock. The significant increase of 74.4% is a positive signal for investors, indicating strong market interest or positive developments within the company. This sharp increase is likely to attract more attention to ASLN, potentially leading to further short-term gains.